LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.070
-0.009 (-0.87%)
May 30, 2025, 4:00 PM - Market closed
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $20.42 million as of May 30, 2025. Its market cap has decreased by -88.59% in one year.
Market Cap
20.42M
Enterprise Value
45.27M
1-Year Change
-88.59%
Ranking
Category
Stock Price
1.07
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $20.42M, a decrease of -91.04%. That is a compound annual growth rate of -46.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 20.60M | -68.80% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |